Physician profile
Carla Rodriguez
NPI 1376036483
$493.77
in general payments reported to CMS, 2019-2025
10 companies · $87.57 in 2025
The $87.57 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.19 · 2023: $67.31 · 2024: $327 · 2025: $87.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $112.90 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $102.34 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $90.29 | 2023-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $65.51 | 2024-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $30.85 | 2023-2024 | Shingrix, Arexvy |
| Haemonetics Corporation | $29.22 | 2024 | Teg6s Hemostasis System |
| Harmony Biosciences LLC | $19.17 | 2024 | |
| Novartis Pharmaceuticals Corporation | $17.40 | 2024 | |
| Amgen INC. | $13.90 | 2025 | Repatha |
| Pfizer INC. | $12.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.